New Ventricular Septal Defects Following Balloon-Expandable Transcatheter Aortic Valve Replacement. J Invasive Cardiol 2016 Jul;28(7):E59-65
Date
06/28/2016Pubmed ID
27342207Scopus ID
2-s2.0-84976428069 (requires institutional sign-in at Scopus site) 3 CitationsAbstract
Transcatheter aortic valve replacement (TAVR) has been commercially approved in the United States for the treatment of high-risk and inoperable patients with severe symptomatic aortic stenosis. While TAVR has proven benefits with regard to survival and quality of life in studied populations, the procedure is also associated with several well-described complications including stroke, vascular injury, and paravalvular regurgitation. More infrequent complications are less well described. Here, we report the development of new ventricular septal defects after TAVR in 4 patients with left ventricular outflow tract calcification. We discuss imaging and post-TAVR management of these patients.
Author List
Rene AG, Jagasia D, Wickramasinghe SR, Desai N, Szeto W, Vallabhajosyula P, Li RH, Silvestry FE, Giri J, Jha S, Herrmann HC, Anwaruddin SAuthor
Saif Anwaruddin MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Aged, 80 and overAortic Valve
Aortic Valve Stenosis
Echocardiography
Female
Heart Septal Defects, Ventricular
Humans
Male
Postoperative Complications
Quality of Life
Reoperation
Risk Assessment
Risk Factors
Severity of Illness Index
Transcatheter Aortic Valve Replacement
